Navigation Links
Pain Medication OTC Manufacturing in Australia Industry Market Research Report Now Available from IBISWorld
Date:5/15/2013

Melbourne, Australia (PRWEB) May 16, 2013

The Pain Medication OTC Manufacturing industry manufactures pharmaceutical products that focus on pain relief and are available without a doctor's permission. As a country with a high awareness of medication and self-medication uses, domestic demand for OTC pain medication has remained healthy over the past five years. This is despite a cautious consumer environment in which consumers have attempted to focus spending on high-value items.

Local manufacturing operations have struggled to benefit from this trend. According to IBISWorld industry analyst Craig Shulman, “global pharmaceutical manufacturing has shifted production towards Asia, where labour is cheaper and the plants are larger, leading to substantial increases in economies of scale.” With these jumps in production capacity, import competition has increased substantially. Australian operations have to deal with higher wage costs. Consequently, this competition is putting pressure on industry profit margins. IBISWorld expects revenue to decrease at an annualised rate of 2.0% over the five years to 2012-13. In 2012-13, revenue is expected to decline 3.3% to reach $834.4 million.

Over the next five years, these trends are expected to continue. Import competition is expected to provide a strong challenge to local manufacturers. “Global pharmaceutical manufacturers are expected to increase their foothold on the global OTC market, as they take advantage of the growing popularity of OTC medication in developing countries and thus improve their global economies of scale,” says Shulman. These growing markets are also new opportunities for Australian manufacturers, which will still have to combat cheaper production methods in these countries as well.

The Pain Medication OTC Manufacturing industry in Australia exhibits a medium level of market share concentration. The top two companies are Pfizer Australia Holdings Pty Limited and GlaxoSmithKline Holdings Pty Ltd.

Over the next five years, many patents are set to expire, with more products and players expected to enter the Pain Medication OTC Manufacturing industry. Established players are likely to extend the life of their former prescription medications by attempting to shift it into the OTC market, pending confirmation from regulators that the products are safe for widespread use without a doctor's prescription. If this is successful, generic brands are expected to follow soon after.

For more information, visit IBISWorld’s Pain Medication OTC Manufacturing report in Australia industry page.

Follow IBISWorld on Twitter: http://twitter.com/#!/ibisworldau

IBISWorld Industry Report Key Topics

Companies in this industry research and develop medicines with pain-relieving, anti-inflammatory and other effects. Products manufactured by the industry are available without a prescription in various OTC locations.

Industry Performance
Executive Summary
Key External Drivers
Current Performance
Industry Outlook
Industry Life Cycle
Products & Markets
Supply Chain
Products & Services
Major Markets
International Trade
Business Locations
Competitive Landscape
Market Share Concentration
Key Success Factors
Cost Structure Benchmarks
Basis of Competition
Barriers to Entry
Industry Globalisation
Major Companies
Operating Conditions
Capital Intensity
Technology & Systems
Revenue Volatility
Regulation & Policy
Industry Assistance
Key Statistics
Industry Data
Annual Change
Key Ratios

About IBISWorld Inc.
Recognised as the nation’s most trusted independent source of industry and market research, IBISWorld offers a comprehensive database of unique information and analysis on every Australian industry. With an extensive online portfolio, valued for its depth and scope, the company equips clients with the insight necessary to make better business decisions. Headquartered in Melbourne, IBISWorld serves a range of business, professional service and government organisations through more than 10 locations worldwide. For more information, visit http://www.ibisworld.com.au or call (03) 9655 3886.

Read the full story at http://www.prweb.com/releases/2013/5/prweb10735532.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Forgoing Medication, for Babys Sake
2. Parents poor math skills may lead to medication errors
3. Reducing off-label use of antipsychotic medications may save money
4. Common acne medication doubles risk of eye infection
5. Misuse of over-the-counter pain medication is potential health threat
6. Genes predict if medication can help you quit smoking
7. Acne Medication May Raise Risk of Eye Infections
8. New delivery method improves efficacy of 2 common Parkinsons disease medications
9. Mount Sinai researcher finds timing of ADHD medication affect academic progress
10. Actos Bladder Cancer Lawsuit Filed in Louisiana Alleging Woman Used Diabetes Medication and Contracted Bladder Cancer, Consumer Justice Foundation Reports
11. Physicians dont adequately monitor patients medication adherence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... ... 24, 2017 , ... Mediaplanet today announces distribution of its ... obstacles facing infection prevention and offer strategies for the health care community to ... , The print component of “Fighting Infection” is distributed within the Friday, March ...
(Date:3/24/2017)... ... March 24, 2017 , ... The Radiology Business Management Association (RBMA) ... awards, now in their 12th year, are among the most prestigious in radiology marketing ... the awards were retooled to recognize achievements in both large budget (over $5,000) and ...
(Date:3/24/2017)... ... March 24, 2017 , ... The iaedp Foundation, the premier provider ... caring for those suffering from the full spectrum of disordered eating, announced today that ... professionals from nearly all 50 states and several countries converged on the Green Valley ...
(Date:3/24/2017)... ... March 24, 2017 , ... ... its innovative EcoQube Frame vertical micro-veggies garden on Kickstarter . Surpassing the ... product – with nearly 2,000 consumers (and counting) already backing the campaign. ...
(Date:3/24/2017)... ... March 24, 2017 , ... On June 9, 2017, ... Claims Litigation seminar in Chicago, Illinois. She will present on: , Filing ... litigated under ERISA involve claims for long-term disability benefits. This session will ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... , March 24, 2017   The Accreditation ... within medical affairs in the pharmaceutical industry has ... chair of a newly formed scientific advisory board. ... to form the first ever medical affairs think ... more information about the ACMA, please visit  www.medicalaffairsspecialist.org ...
(Date:3/24/2017)... FinancialBuzz.com News Commentary   ... Medical cannabis products around the world are projected to gain popularity. ... cannabis market will reach a value of USD 55.8 billion by 2025. ... new growing industry. By the end of 2016, 28 states have now ... More conservative states like Arkansas and ...
(Date:3/24/2017)... , March 24, 2017 A ReportsnReports.com ... has been growing rapidly as the global sales of Adcetris and ... growth in the antibody drug conjugates market is driven by large ... cancer and wider therapeutic window offered by ADCs. ... Browse 3 Tables and 94 Figures, ...
Breaking Medicine Technology: